Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Dosing initiates in phase I study of GFB-024 in severe insulin-resistant diabetic nephropathy

May 14, 2021

Nephraegis Therapeutics to develop NPH-022 for the prevention and treatment of AKI

May 13, 2021

Phase III FIGARO-DKD cardiovascular outcomes study of finerenone meets primary endpoint

May 10, 2021

Benlysta approved in E.U. for active lupus nephritis

May 6, 2021

European Commission approves Sibnayal for distal renal tubular acidosis

May 5, 2021

Topline data presented from first cohort of phase Ib trial of RGLS-4326

May 4, 2021

FDA approves Farxiga for chronic kidney disease

May 3, 2021

Pooled data from the AURORA and AURA-LV trials across lupus nephritis biopsy classes

April 12, 2021

X-Chem discloses new HAOX1 inhibitors

April 8, 2021

First patient dosed in phase II AFFINITY basket study of atrasentan

April 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...